PEG-MGF | Reference Standard

Skeletal Muscle Regeneration, Satellite Cell Activation & Inflammation Modulation Research

Category:
Muscle Biology • Regenerative Signaling • IGF-1 Axis Derivatives • Exercise & Injury Recovery Research

 

What Researchers Study

PEG-MGF (Pegylated Mechano Growth Factor) is a modified, long-acting derivative of Mechano Growth Factor (MGF), itself an alternative splice variant of Insulin-Like Growth Factor-1 (IGF-1). MGF is endogenously expressed in skeletal muscle following mechanical stress, resistance loading, or injury, where it plays a critical role in muscle repair rather than systemic growth signaling.

Researchers study PEG-MGF because it preferentially supports:

• Myoblast proliferation

• Satellite (muscle stem) cell activation

• Local tissue repair signaling

• Inflammation-regulated regeneration

Pegylation (PEG conjugation) dramatically extends the peptide’s functional half-life, allowing sustained signaling that is otherwise impossible with native MGF.

 

Primary Signal Pathways Studied

PEG-MGF research focuses on:

• IGF-1 splice-variant signaling

• Satellite cell (Pax7⁺) activation

• Myoblast proliferation vs differentiation balance

• Macrophage–muscle crosstalk

• Cytokine and chemokine modulation

• Extracellular matrix remodeling and fibrosis regulation

 

Why PEG-MGF Is Studied

Native MGF has a biological half-life of approximately 5–7 minutes, severely limiting its utility in controlled research environments. Pegylation:

• Extends half-life to approximately 48–72 hours

• Improves peptide stability in circulation

• Allows sustained exposure to regenerating tissue

• Enables clearer investigation of downstream signaling effects

Importantly, PEG itself is biologically inert, does not activate receptors, and is eliminated renally, making it an ideal stabilizing modification for research peptides.

 

Mechanistic Overview

MGF differs from systemic IGF-1 in both structure and biological intent:

• IGF-1: Promotes differentiation and hypertrophy

• MGF: Promotes proliferation and repair initiation

PEG-MGF primarily stimulates muscle precursor cell division, increasing the pool of cells available to later fuse with existing muscle fibers. This makes it especially valuable in early-phase regeneration models, rather than late-stage hypertrophy studies.

 

Key Research Findings

1. Muscle Injury & Regeneration Models

Research indicates that PEG-MGF influences the inflammatory environment surrounding injured muscle.

Key observations include:

• Reduction in fibrosis following injury

• Decreased expression of inflammatory cytokines

• Suppression of oxidative stress markers

• Downregulation of matrix metalloproteinases (MMPs)

Liu et al., 2019 demonstrated that while MGF did not directly protect muscle fibers after macrophage depletion, it significantly reduced fibrosis and inflammatory signaling, suggesting its role is regulatory rather than structural.
🔗 https://pubmed.ncbi.nlm.nih.gov/31164836/

 

2. Macrophage & Cytokine Interaction

MGF expression is tightly coupled to immune cell dynamics.

Sun et al., 2018 showed:

• MGF expression rises sharply following muscle injury

• Increased MGF coincides with macrophage and neutrophil infiltration

• Macrophages actively regulate MGF signaling levels

This establishes PEG-MGF as a bridge molecule between immune response and regenerative signaling.
🔗 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094977/

 

3. Anti-Fibrotic & ECM Regulation Research

PEG-MGF is studied for its ability to:

• Limit excessive collagen deposition

• Reduce scar tissue formation

• Preserve muscle elasticity during regeneration

These effects are particularly relevant in:

• Chronic injury models

• Overuse or strain paradigms

• Aging muscle repair research

 

Research Context & Considerations

• PEG-MGF favors cell proliferation, not differentiation

• Timing and exposure duration are critical variables

• Excessive or prolonged signaling may alter tissue architecture

• Best studied in localized or early-phase regeneration models

 

Product Specifications

• Compound Name: PEG-MGF (Pegylated Mechano Growth Factor)

• CAS Number: N/A (modified IGF-1 splice variant)

• Molecular Formula: Variable (4000–6000)

• Molecular Weight: 2867 Core + PEG 

• Peptide Class: IGF-1 splice variant (MGF)

• Purity: ≥98% (HPLC verified)

• Form: Lyophilized powder

• Appearance: White to off-white solid

• Storage: ≤ –20 °C, desiccated, protected from light

 

Batch Documentation & Traceability

Each vial is shipped with a lot-specific QR code that provides secure access to batch documentation, including:

• Certificate of Analysis (COA)
• Identity verification report (HPLC / MS)
• Lot number, potency, and expiration

Documentation is locked to the specific batch shipped to ensure traceability, version control, and research reproducibility.

QR access is provided with the physical product and is not reused across lots.

 

Research Use Disclaimer

This compound is supplied exclusively for laboratory research purposes.
Not for human or veterinary use.
Not for diagnostic, therapeutic, or consumptive applications.